1 enrolling by invitation. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Dementia, Mild: new trials by email Literature Review of Dementia, Mild trials Research Report on Dementia, Mild
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tau PET Outcomes With Anti-amyloid Immunotherapies 18F-AV-1451, C-11 ER-176 - Cognitive Impairment, Mild, Dementia, Mild | Phase 2 | Enrolling by invitation | Mayo Clinic | 135 | 2025-11-04 | 2026-10-30 |
Alzheimer Disease (1) · Cognitive Dysfunction (1) · Dementia (1) · Lymphoma, Follicular (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Cognition Disorders (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Mental Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1)
7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (1)
Mayo Clinic (1)
United States (1)